Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$217M |
| 2 |
JPMorgan Chase
JPM
|
+$213M |
| 3 |
Intel
INTC
|
+$200M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$184M |
| 5 |
TECD
Tech Data Corp
TECD
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$685M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$127M |
| 3 |
Meta Platforms (Facebook)
META
|
+$122M |
| 4 |
Merck
MRK
|
+$110M |
| 5 |
NVIDIA
NVDA
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 8.62% |
| 2 | Technology | 7.54% |
| 3 | Financials | 6.93% |
| 4 | Consumer Discretionary | 6.74% |
| 5 | Industrials | 6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZEPP
1601
Zepp Health
ZEPP
$64.2M
| $5.7M | 0.01% |
115,339
+58,930
| +104% | +$2.72M |
|
|
ADVM
1602
DELISTED
Adverum Biotechnologies
ADVM
| $5.7M | 0.01% |
27,296
-10,505
| -28% | -$1.86M |
|
1603
Aramark
ARMK
$15B
| $5.7M | 0.01% |
349,505
+332,737
| +1,984% | +$5.84M |
|
1604
PUT
Deere & Co
DE
$165B
| $5.69M | 0.01% |
36,200
-15,800
| -30% | -$2.29M |
|
1605
Regenxbio
RGNX
$629M
| $5.68M | 0.01% |
+154,344
| New | +$5.75M |
|
|
CMD
1606
DELISTED
Cantel Medical Corporation
CMD
| $5.68M | 0.01% |
128,433
-561,313
| -81% | -$20.9M |
|
|
PARA
1607
DELISTED
Paramount Global Class B
PARA
| $5.67M | 0.01% |
243,227
+131,802
| +118% | +$2.54M |
|
1608
Forward Air
FWRD
$452M
| $5.67M | 0.01% |
113,739
-131,427
| -54% | -$6.45M |
|
1609
Advanced Energy
AEIS
$11.7B
| $5.66M | 0.01% |
+83,531
| New | +$4.98M |
|
1610
Kiniksa Pharmaceuticals
KNSA
$5.68B
| $5.66M | 0.01% |
222,246
+42,617
| +24% | +$890K |
|
1611
CTS Corp
CTS
$1.84B
| $5.65M | 0.01% |
282,157
+64,218
| +29% | +$1.38M |
|
1612
Williams-Sonoma
WSM
$27.6B
| $5.65M | 0.01% |
+137,892
| New | +$4.69M |
|
|
DOYU
1613
DouYu International Holdings
DOYU
$141M
| $5.65M | 0.01% |
48,952
+47,710
| +3,841% | +$3.98M |
|
1614
Hudbay
HBM
$10.3B
| $5.64M | 0.01% |
1,862,305
+486,843
| +35% | +$1.22M |
|
1615
Maximus
MMS
$3.24B
| $5.64M | 0.01% |
80,106
+69,685
| +669% | +$4.69M |
|
1616
John Wiley & Sons Class A
WLY
$2.67B
| $5.64M | 0.01% |
144,509
-57,401
| -28% | -$2.19M |
|
1617
RH
RH
$3.17B
| $5.63M | 0.01% |
22,633
+8,639
| +62% | +$1.57M |
|
1618
ArcelorMittal
MT
$53.6B
| $5.63M | 0.01% |
524,452
+380,490
| +264% | +$3.84M |
|
1619
PUT
McKesson
MCK
$99.6B
| $5.62M | 0.01% |
+36,600
| New | +$5.29M |
|
1620
Designer Brands
DBI
$324M
| $5.61M | 0.01% |
828,806
+347,786
| +72% | +$2.1M |
|
1621
Axcelis
ACLS
$4.03B
| $5.6M | 0.01% |
201,213
+184,529
| +1,106% | +$4.5M |
|
1622
Comfort Systems
FIX
$61.5B
| $5.6M | 0.01% |
137,468
-18,172
| -12% | -$646K |
|
1623
Celldex Therapeutics
CLDX
$3.01B
| $5.6M | 0.01% |
+430,564
| New | +$1.91M |
|
1624
Ormat Technologies
ORA
$5.95B
| $5.6M | 0.01% |
+88,144
| New | +$5.77M |
|
1625
Brown & Brown
BRO
$23.9B
| $5.59M | 0.01% |
137,227
-151,734
| -53% | -$5.85M |
|
Similar funds
Millennium Management's Q2 2020 Portfolio in Review
As of Q2 2020, Millennium Management held 4,914 positions worth $73B, up 64% from $44.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Millennium Management deployed $17.6B of net new capital in Q2 2020, opening 1,140 new positions and adding to 1,565 existing holdings. Its largest new stake was Global Payments: 1,008,446 shares worth $171M.
By sector, the portfolio is most concentrated in Healthcare at 8.6% of assets, down from 11% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $127M trimmed.
- Millennium Management's largest Q2 2020 buy was Global Payments: 1,008,446 shares worth $171M.
- Millennium Management added most to Lowe's Companies in Q2 2020, an estimated $217M increase.
- Millennium Management's biggest Q2 2020 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $127M.
- Millennium Management fully exited Allergan plc in Q2 2020, selling an estimated $685M.
- Millennium Management's ten largest holdings make up 20% of its $73B portfolio in Q2 2020.
- Millennium Management opened 1,140 new positions and closed 798 in Q2 2020.
- Millennium Management's portfolio value rose 64% quarter-over-quarter to $73B.
Based on Millennium Management's 13F filing for Q2 2020, filed 14 Aug 2020.